VIELA BIO, INC. Cash and securities
- Total cash · latest quarter (USD): Value $367.69M; Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2020-12-31..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2020-12-31..
Cash and securities
Overview →Financial period ending 2020-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | $367.69M | Cash and cash equivalents plus current marketable securities. Period ending 2020-12-31. $130.06M + $237.62M ≈ $367.69M |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2020-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 130.06M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 237.62M USD | Marketable Securities, Current |
| Cash and current securities | 367.69M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2020-12-31 | $367.69M | (m) | $130.06M | $237.62M | (m) |
| 2020-09-30 | $385.18M | (m) | $111.65M | $273.53M | (m) |
| 2020-06-30 | $425.55M | (m) | $131.55M | $294.00M | (m) |
| 2020-03-31 | $314.83M | (m) | $163.57M | $151.25M | (m) |
| 2019-12-31 | $314.80M | (m) | $200.85M | $113.94M | (m) |
| 2019-09-30 | $198.24M | (m) | $155.75M | $42.49M | (m) |
| 2018-12-31 | (m) | (m) | $126.90M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.